Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

Over the past two years, Philip Morris has outperformed expectations consistently, beating EPS and revenue estimates 88% of ...

We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...

Discover insights on Enphase Energy's upcoming Q2 earnings, industry challenges from downgraded forecasts, tax credit phaseouts, and evolving solar trends.